|Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes|
BO Ahrén, E Simonsson, H Larsson, M Landin-Olsson, H Torgeirsson, ...
Diabetes care 25 (5), 869-875, 2002
|Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes …|
B Littorin, P Blom, A Schölin, HJ Arnqvist, G Blohme, J Bolinder, ...
Diabetologia 49 (12), 2847-2852, 2006
|Fat cell enlargement is an independent marker of insulin resistance and ‘hyperleptinaemia’|
M Lundgren, M Svensson, S Lindmark, F Renström, T Ruge, JW Eriksson
Diabetologia 50 (3), 625-633, 2007
|Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs …|
KI Birkeland, ME Jørgensen, B Carstensen, F Persson, HL Gulseth, ...
The lancet Diabetes & endocrinology 5 (9), 709-717, 2017
|Regional differences of insulin action in adipose tissue: insights from in vivo and in vitro studies|
F Giorgino, L Laviola, JW Eriksson
Acta Physiologica Scandinavica 183 (1), 13-30, 2005
|The incidence of type I diabetes has not increased but shifted to a younger age at diagnosis in the 0–34 years group in Sweden 1983 to 1998|
A Pundziute-Lyckå, G Dahlquist, L Nyström, H Arnqvist, E Björk, G Blohme, ...
Diabetologia 45 (6), 783-791, 2002
|Early glycemic control, age at onset, and development of microvascular complications in childhood-onset type 1 diabetes: a population-based study in northern Sweden|
M Svensson, JW Eriksson, G Dahlquist
Diabetes care 27 (4), 955-962, 2004
|Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised …|
P Dandona, C Mathieu, M Phillip, L Hansen, SC Griffen, D Tschöpe, ...
The lancet Diabetes & endocrinology 5 (11), 864-876, 2017
|The risk of venous thromboembolism is markedly elevated in patients with diabetes|
V Petrauskiene, M Falk, I Waernbaum, M Norberg, JW Eriksson
Diabetologia 48 (5), 1017-1021, 2005
|Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study|
JW Eriksson, P Lundkvist, PA Jansson, L Johansson, M Kvarnström, ...
Diabetologia 61 (9), 1923-1934, 2018
|Dexamethasone impairs insulin signalling and glucose transport by depletion of insulin receptor substrate-1, phosphatidylinositol 3-kinase and protein kinase B in primary …|
J Burén, HX Liu, J Jensen, JW Eriksson
European journal of endocrinology 146 (3), 419-429, 2002
|Glucocorticoids down-regulate glucose uptake capacity and insulin-signaling proteins in omental but not subcutaneous human adipocytes|
M Lundgren, J Burén, T Ruge, T Myrnas, JW Eriksson
The Journal of Clinical Endocrinology & Metabolism 89 (6), 2989-2997, 2004
|The incidence of retinopathy 10 years after diagnosis in young adult people with diabetes: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS)|
M Henricsson, L Nyström, G Blohme, JAN Ostman, C Kullberg, ...
Diabetes care 26 (2), 349-354, 2003
|Postprandial hypertriglyceridemia and insulin resistance in normoglycemic first-degree relatives of patients with type 2 diabetes|
M Axelsen, U Smith, JW Eriksson, MR Taskinen, PA Jansson
Annals of internal medicine 131 (1), 27-31, 1999
|Metabolic stress in insulin’s target cells leads to ROS accumulation–a hypothetical common pathway causing insulin resistance|
FEBS letters 581 (19), 3734-3742, 2007
|Dapagliflozin is associated with lower risk of cardiovascular events and all‐cause mortality in people with type 2 diabetes (CVD‐REAL Nordic) when compared with dipeptidyl …|
F Persson, T Nyström, ME Jørgensen, B Carstensen, HL Gulseth, ...
Diabetes, Obesity and Metabolism 20 (2), 344-351, 2018
|Low cellular IRS 1 gene and protein expression predict insulin resistance and NIDDM|
E CARVALHO, PERA JANSSON, M AXELSEN, JW Eriksson, X HUANG, ...
The FASEB Journal 13 (15), 2173-2178, 1999
|Fatty acid profile of the erythrocyte membrane preceding development of Type 2 diabetes mellitus|
B Krachler, M Norberg, JW Eriksson, G Hallmans, I Johansson, B Vessby, ...
Nutrition, Metabolism and Cardiovascular Diseases 18 (7), 503-510, 2008
|Gender differences and temporal variation in the incidence of type 1 diabetes: results of 8012 cases in the nationwide Diabetes Incidence Study in Sweden 1983–2002|
J Östman, G Lönnberg, HJ Arnqvist, G Blohme, J Bolinder, AE Schnell, ...
Journal of internal medicine 263 (4), 386-394, 2008
|Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: the DEPICT-1 52-week study|
P Dandona, C Mathieu, M Phillip, L Hansen, D Tschöpe, F Thorén, J Xu, ...
Diabetes Care 41 (12), 2552-2559, 2018